Therapeutic Strategies for Metastatic Colorectal Cancer: Simultaneous, Sequential, or Specific?
- 15 October 2003
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (20) , 3716-3717
- https://doi.org/10.1200/jco.2003.07.941
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Phase I and Pharmacokinetic Study of Two Different Schedules of Oxaliplatin, Irinotecan, Fluorouracil, and Leucovorin in Patients With Solid TumorsJournal of Clinical Oncology, 2003
- Oxaliplatin plus irinotecan and leucovorin-modulated5-fluorouracil triplet regimen every other week:a dose-finding study in patients with advanced gastrointestinal malignanciesAnnals of Oncology, 2002
- Combined Irinotecan, Oxaliplatin and 5-Fluorouracil in Patients with Advanced Colorectal CancerOncology, 2002
- Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell linesBritish Journal of Cancer, 2001
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialPublished by Elsevier ,2000
- Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal CancerJournal of Clinical Oncology, 2000
- A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerAnnals of Oncology, 1998